BN 52115

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H584239

CAS#: 120908-94-3

Description: BN 52115 is a platelet activating factor antagonist that has been found to inhibit in vivo bronchopulmonary alteration.

Chemical Structure

img
BN 52115
CAS# 120908-94-3
Instruction

Theoretical Analysis

Hodoodo Cat#: H584239
Name: BN 52115
CAS#: 120908-94-3
Chemical Formula: C37H60BrNO4
Exact Mass: 661.37
Molecular Weight: 662.794
Elemental Analysis: C, 67.05; H, 9.13; Br, 12.06; N, 2.11; O, 9.66

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: BN 52115; BN-52115; BN52115

IUPAC/Chemical Name: Quinolinium, 1-(6-((2-heptadecyl-2-methyl-1,3-dioxolan-4-yl)methoxy)-6-oxohexyl)-, bromide

InChi Key: FTFOSFBACGPTIP-UHFFFAOYSA-M

InChi Code: InChI=1S/C37H60NO4.BrH/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-21-28-37(2)41-32-34(42-37)31-40-36(39)27-18-17-22-29-38-30-23-25-33-24-19-20-26-35(33)38;/h19-20,23-26,30,34H,3-18,21-22,27-29,31-32H2,1-2H3;1H/q+1;/p-1

SMILES Code: O=C(OCC1OC(C)(CCCCCCCCCCCCCCCCC)OC1)CCCCC[N+]2=C3C=CC=CC3=CC=C2.[Br-]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 662.79 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Pons F, Touvay C, Lejeune V, Carré C, Vilain B, Broquet C, Mencia-Huerta JM, Braquet P. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig. J Lipid Mediat. 1989 Nov-Dec;1(6):329-40. PubMed PMID: 2519901.

2: Miller LG, Bazan NG, Roy RB, Clostre F, Gaver A, Braquet P. Platelet activating factor antagonists interact with GABAA receptors. Res Commun Chem Pathol Pharmacol. 1991 Nov;74(2):253-6. PubMed PMID: 1667341.

3: Domingo MT, Piro F, Broquet C, Auclair E, Chabrier PE, Braquet P. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists. Lipids. 1992 Aug;27(8):582-6. PubMed PMID: 1328798.